Remarkable funding support for becoming a biotech unicorn
HONG KONG SAR -
Media OutReach Newswire - 26 June 2024 - Immuno Cure BioTech ("
Immuno Cure") is delighted to announce its recent successful admission to the prestigious Elite Programme of Hong Kong Science & Technology Park ("
HKSTP"), positioning the company for accelerated growth and innovation in the field of biotechnology in Hong Kong.